[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Inhalers Market Growth 2022-2028

January 2022 | 100 pages | ID: G2A9E982E58DEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Inhalers will have significant change from previous year. According to our (LP Information) latest study, the global Inhalers market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Inhalers market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Inhalers market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Inhalers market, reaching US$ million by the year 2028. As for the Europe Inhalers landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Inhalers players cover GlaxoSmithKline, Merck, AstraZeneca, and Boehringer-Ingelheim, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Inhalers market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
  • Metered Dose Inhalers
  • Dry Powder Inhalers
  • Nasal Inhalers
  • Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
  • Hospital
  • Clinic
  • Respiratory Care Centers
  • Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
  • GlaxoSmithKline
  • Merck
  • AstraZeneca
  • Boehringer-Ingelheim
  • 3M
  • Teva
  • Sunovion Pharmaceuticals
  • Aristopharma
  • Novartis
  • Vectura Group
  • MannKind
  • Respirices
  • Orion Pharm
  • Hovione
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Inhalers Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Inhalers by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Inhalers by Country/Region, 2017, 2022 & 2028
2.2 Inhalers Segment by Type
  2.2.1 Metered Dose Inhalers
  2.2.2 Dry Powder Inhalers
  2.2.3 Nasal Inhalers
  2.2.4 Other
2.3 Inhalers Sales by Type
  2.3.1 Global Inhalers Sales Market Share by Type (2017-2022)
  2.3.2 Global Inhalers Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Inhalers Sale Price by Type (2017-2022)
2.4 Inhalers Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Respiratory Care Centers
  2.4.4 Others
2.5 Inhalers Sales by Application
  2.5.1 Global Inhalers Sale Market Share by Application (2017-2022)
  2.5.2 Global Inhalers Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Inhalers Sale Price by Application (2017-2022)

3 GLOBAL INHALERS BY COMPANY

3.1 Global Inhalers Breakdown Data by Company
  3.1.1 Global Inhalers Annual Sales by Company (2020-2022)
  3.1.2 Global Inhalers Sales Market Share by Company (2020-2022)
3.2 Global Inhalers Annual Revenue by Company (2020-2022)
  3.2.1 Global Inhalers Revenue by Company (2020-2022)
  3.2.2 Global Inhalers Revenue Market Share by Company (2020-2022)
3.3 Global Inhalers Sale Price by Company
3.4 Key Manufacturers Inhalers Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Inhalers Product Location Distribution
  3.4.2 Players Inhalers Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR INHALERS BY GEOGRAPHIC REGION

4.1 World Historic Inhalers Market Size by Geographic Region (2017-2022)
  4.1.1 Global Inhalers Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Inhalers Annual Revenue by Geographic Region
4.2 World Historic Inhalers Market Size by Country/Region (2017-2022)
  4.2.1 Global Inhalers Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Inhalers Annual Revenue by Country/Region
4.3 Americas Inhalers Sales Growth
4.4 APAC Inhalers Sales Growth
4.5 Europe Inhalers Sales Growth
4.6 Middle East & Africa Inhalers Sales Growth

5 AMERICAS

5.1 Americas Inhalers Sales by Country
  5.1.1 Americas Inhalers Sales by Country (2017-2022)
  5.1.2 Americas Inhalers Revenue by Country (2017-2022)
5.2 Americas Inhalers Sales by Type
5.3 Americas Inhalers Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Inhalers Sales by Region
  6.1.1 APAC Inhalers Sales by Region (2017-2022)
  6.1.2 APAC Inhalers Revenue by Region (2017-2022)
6.2 APAC Inhalers Sales by Type
6.3 APAC Inhalers Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Inhalers by Country
  7.1.1 Europe Inhalers Sales by Country (2017-2022)
  7.1.2 Europe Inhalers Revenue by Country (2017-2022)
7.2 Europe Inhalers Sales by Type
7.3 Europe Inhalers Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Inhalers by Country
  8.1.1 Middle East & Africa Inhalers Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Inhalers Revenue by Country (2017-2022)
8.2 Middle East & Africa Inhalers Sales by Type
8.3 Middle East & Africa Inhalers Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inhalers
10.3 Manufacturing Process Analysis of Inhalers
10.4 Industry Chain Structure of Inhalers

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Inhalers Distributors
11.3 Inhalers Customer

12 WORLD FORECAST REVIEW FOR INHALERS BY GEOGRAPHIC REGION

12.1 Global Inhalers Market Size Forecast by Region
  12.1.1 Global Inhalers Forecast by Region (2023-2028)
  12.1.2 Global Inhalers Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Inhalers Forecast by Type
12.7 Global Inhalers Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 GlaxoSmithKline
  13.1.1 GlaxoSmithKline Company Information
  13.1.2 GlaxoSmithKline Inhalers Product Offered
  13.1.3 GlaxoSmithKline Inhalers Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 GlaxoSmithKline Main Business Overview
  13.1.5 GlaxoSmithKline Latest Developments
13.2 Merck
  13.2.1 Merck Company Information
  13.2.2 Merck Inhalers Product Offered
  13.2.3 Merck Inhalers Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Merck Main Business Overview
  13.2.5 Merck Latest Developments
13.3 AstraZeneca
  13.3.1 AstraZeneca Company Information
  13.3.2 AstraZeneca Inhalers Product Offered
  13.3.3 AstraZeneca Inhalers Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 AstraZeneca Main Business Overview
  13.3.5 AstraZeneca Latest Developments
13.4 Boehringer-Ingelheim
  13.4.1 Boehringer-Ingelheim Company Information
  13.4.2 Boehringer-Ingelheim Inhalers Product Offered
  13.4.3 Boehringer-Ingelheim Inhalers Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 Boehringer-Ingelheim Main Business Overview
  13.4.5 Boehringer-Ingelheim Latest Developments
13.5 3M
  13.5.1 3M Company Information
  13.5.2 3M Inhalers Product Offered
  13.5.3 3M Inhalers Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 3M Main Business Overview
  13.5.5 3M Latest Developments
13.6 Teva
  13.6.1 Teva Company Information
  13.6.2 Teva Inhalers Product Offered
  13.6.3 Teva Inhalers Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Teva Main Business Overview
  13.6.5 Teva Latest Developments
13.7 Sunovion Pharmaceuticals
  13.7.1 Sunovion Pharmaceuticals Company Information
  13.7.2 Sunovion Pharmaceuticals Inhalers Product Offered
  13.7.3 Sunovion Pharmaceuticals Inhalers Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 Sunovion Pharmaceuticals Main Business Overview
  13.7.5 Sunovion Pharmaceuticals Latest Developments
13.8 Aristopharma
  13.8.1 Aristopharma Company Information
  13.8.2 Aristopharma Inhalers Product Offered
  13.8.3 Aristopharma Inhalers Sales, Revenue, Price and Gross Margin (2020-2022)
  13.8.4 Aristopharma Main Business Overview
  13.8.5 Aristopharma Latest Developments
13.9 Novartis
  13.9.1 Novartis Company Information
  13.9.2 Novartis Inhalers Product Offered
  13.9.3 Novartis Inhalers Sales, Revenue, Price and Gross Margin (2020-2022)
  13.9.4 Novartis Main Business Overview
  13.9.5 Novartis Latest Developments
13.10 Vectura Group
  13.10.1 Vectura Group Company Information
  13.10.2 Vectura Group Inhalers Product Offered
  13.10.3 Vectura Group Inhalers Sales, Revenue, Price and Gross Margin (2020-2022)
  13.10.4 Vectura Group Main Business Overview
  13.10.5 Vectura Group Latest Developments
13.11 MannKind
  13.11.1 MannKind Company Information
  13.11.2 MannKind Inhalers Product Offered
  13.11.3 MannKind Inhalers Sales, Revenue, Price and Gross Margin (2020-2022)
  13.11.4 MannKind Main Business Overview
  13.11.5 MannKind Latest Developments
13.12 Respirices
  13.12.1 Respirices Company Information
  13.12.2 Respirices Inhalers Product Offered
  13.12.3 Respirices Inhalers Sales, Revenue, Price and Gross Margin (2020-2022)
  13.12.4 Respirices Main Business Overview
  13.12.5 Respirices Latest Developments
13.13 Orion Pharm
  13.13.1 Orion Pharm Company Information
  13.13.2 Orion Pharm Inhalers Product Offered
  13.13.3 Orion Pharm Inhalers Sales, Revenue, Price and Gross Margin (2020-2022)
  13.13.4 Orion Pharm Main Business Overview
  13.13.5 Orion Pharm Latest Developments
13.14 Hovione
  13.14.1 Hovione Company Information
  13.14.2 Hovione Inhalers Product Offered
  13.14.3 Hovione Inhalers Sales, Revenue, Price and Gross Margin (2020-2022)
  13.14.4 Hovione Main Business Overview
  13.14.5 Hovione Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Inhalers Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Inhalers Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Metered Dose Inhalers
Table 4. Major Players of Dry Powder Inhalers
Table 5. Major Players of Nasal Inhalers
Table 6. Major Players of Other
Table 7. Global Inhalers Sales by Type (2017-2022) & (K Units)
Table 8. Global Inhalers Sales Market Share by Type (2017-2022)
Table 9. Global Inhalers Revenue by Type (2017-2022) & ($ million)
Table 10. Global Inhalers Revenue Market Share by Type (2017-2022)
Table 11. Global Inhalers Sale Price by Type (2017-2022) & (USD/Unit)
Table 12. Global Inhalers Sales by Application (2017-2022) & (K Units)
Table 13. Global Inhalers Sales Market Share by Application (2017-2022)
Table 14. Global Inhalers Revenue by Application (2017-2022)
Table 15. Global Inhalers Revenue Market Share by Application (2017-2022)
Table 16. Global Inhalers Sale Price by Application (2017-2022) & (USD/Unit)
Table 17. Global Inhalers Sales by Company (2020-2022) & (K Units)
Table 18. Global Inhalers Sales Market Share by Company (2020-2022)
Table 19. Global Inhalers Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Inhalers Revenue Market Share by Company (2020-2022)
Table 21. Global Inhalers Sale Price by Company (2020-2022) & (USD/Unit)
Table 22. Key Manufacturers Inhalers Producing Area Distribution and Sales Area
Table 23. Players Inhalers Products Offered
Table 24. Inhalers Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Inhalers Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Inhalers Sales Market Share Geographic Region (2017-2022)
Table 29. Global Inhalers Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Inhalers Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Inhalers Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Inhalers Sales Market Share by Country/Region (2017-2022)
Table 33. Global Inhalers Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Inhalers Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Inhalers Sales by Country (2017-2022) & (K Units)
Table 36. Americas Inhalers Sales Market Share by Country (2017-2022)
Table 37. Americas Inhalers Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Inhalers Revenue Market Share by Country (2017-2022)
Table 39. Americas Inhalers Sales by Type (2017-2022) & (K Units)
Table 40. Americas Inhalers Sales Market Share by Type (2017-2022)
Table 41. Americas Inhalers Sales by Application (2017-2022) & (K Units)
Table 42. Americas Inhalers Sales Market Share by Application (2017-2022)
Table 43. APAC Inhalers Sales by Region (2017-2022) & (K Units)
Table 44. APAC Inhalers Sales Market Share by Region (2017-2022)
Table 45. APAC Inhalers Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Inhalers Revenue Market Share by Region (2017-2022)
Table 47. APAC Inhalers Sales by Type (2017-2022) & (K Units)
Table 48. APAC Inhalers Sales Market Share by Type (2017-2022)
Table 49. APAC Inhalers Sales by Application (2017-2022) & (K Units)
Table 50. APAC Inhalers Sales Market Share by Application (2017-2022)
Table 51. Europe Inhalers Sales by Country (2017-2022) & (K Units)
Table 52. Europe Inhalers Sales Market Share by Country (2017-2022)
Table 53. Europe Inhalers Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Inhalers Revenue Market Share by Country (2017-2022)
Table 55. Europe Inhalers Sales by Type (2017-2022) & (K Units)
Table 56. Europe Inhalers Sales Market Share by Type (2017-2022)
Table 57. Europe Inhalers Sales by Application (2017-2022) & (K Units)
Table 58. Europe Inhalers Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Inhalers Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Inhalers Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Inhalers Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Inhalers Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Inhalers Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Inhalers Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Inhalers Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Inhalers Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Inhalers
Table 68. Key Market Challenges & Risks of Inhalers
Table 69. Key Industry Trends of Inhalers
Table 70. Inhalers Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Inhalers Distributors List
Table 73. Inhalers Customer List
Table 74. Global Inhalers Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Inhalers Sales Market Forecast by Region
Table 76. Global Inhalers Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Inhalers Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Inhalers Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Inhalers Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Inhalers Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Inhalers Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Inhalers Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Inhalers Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Inhalers Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Inhalers Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Inhalers Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Inhalers Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Inhalers Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Inhalers Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Inhalers Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Inhalers Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Inhalers Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Inhalers Revenue Market Share Forecast by Application (2023-2028)
Table 94. GlaxoSmithKline Basic Information, Inhalers Manufacturing Base, Sales Area and Its Competitors
Table 95. GlaxoSmithKline Inhalers Product Offered
Table 96. GlaxoSmithKline Inhalers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 97. GlaxoSmithKline Main Business
Table 98. GlaxoSmithKline Latest Developments
Table 99. Merck Basic Information, Inhalers Manufacturing Base, Sales Area and Its Competitors
Table 100. Merck Inhalers Product Offered
Table 101. Merck Inhalers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 102. Merck Main Business
Table 103. Merck Latest Developments
Table 104. AstraZeneca Basic Information, Inhalers Manufacturing Base, Sales Area and Its Competitors
Table 105. AstraZeneca Inhalers Product Offered
Table 106. AstraZeneca Inhalers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 107. AstraZeneca Main Business
Table 108. AstraZeneca Latest Developments
Table 109. Boehringer-Ingelheim Basic Information, Inhalers Manufacturing Base, Sales Area and Its Competitors
Table 110. Boehringer-Ingelheim Inhalers Product Offered
Table 111. Boehringer-Ingelheim Inhalers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 112. Boehringer-Ingelheim Main Business
Table 113. Boehringer-Ingelheim Latest Developments
Table 114. 3M Basic Information, Inhalers Manufacturing Base, Sales Area and Its Competitors
Table 115. 3M Inhalers Product Offered
Table 116. 3M Inhalers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 117. 3M Main Business
Table 118. 3M Latest Developments
Table 119. Teva Basic Information, Inhalers Manufacturing Base, Sales Area and Its Competitors
Table 120. Teva Inhalers Product Offered
Table 121. Teva Inhalers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 122. Teva Main Business
Table 123. Teva Latest Developments
Table 124. Sunovion Pharmaceuticals Basic Information, Inhalers Manufacturing Base, Sales Area and Its Competitors
Table 125. Sunovion Pharmaceuticals Inhalers Product Offered
Table 126. Sunovion Pharmaceuticals Inhalers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 127. Sunovion Pharmaceuticals Main Business
Table 128. Sunovion Pharmaceuticals Latest Developments
Table 129. Aristopharma Basic Information, Inhalers Manufacturing Base, Sales Area and Its Competitors
Table 130. Aristopharma Inhalers Product Offered
Table 131. Aristopharma Inhalers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 132. Aristopharma Main Business
Table 133. Aristopharma Latest Developments
Table 134. Novartis Basic Information, Inhalers Manufacturing Base, Sales Area and Its Competitors
Table 135. Novartis Inhalers Product Offered
Table 136. Novartis Inhalers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 137. Novartis Main Business
Table 138. Novartis Latest Developments
Table 139. Vectura Group Basic Information, Inhalers Manufacturing Base, Sales Area and Its Competitors
Table 140. Vectura Group Inhalers Product Offered
Table 141. Vectura Group Inhalers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 142. Vectura Group Main Business
Table 143. Vectura Group Latest Developments
Table 144. MannKind Basic Information, Inhalers Manufacturing Base, Sales Area and Its Competitors
Table 145. MannKind Inhalers Product Offered
Table 146. MannKind Inhalers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 147. MannKind Main Business
Table 148. MannKind Latest Developments
Table 149. Respirices Basic Information, Inhalers Manufacturing Base, Sales Area and Its Competitors
Table 150. Respirices Inhalers Product Offered
Table 151. Respirices Inhalers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 152. Respirices Main Business
Table 153. Respirices Latest Developments
Table 154. Orion Pharm Basic Information, Inhalers Manufacturing Base, Sales Area and Its Competitors
Table 155. Orion Pharm Inhalers Product Offered
Table 156. Orion Pharm Inhalers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 157. Orion Pharm Main Business
Table 158. Orion Pharm Latest Developments
Table 159. Hovione Basic Information, Inhalers Manufacturing Base, Sales Area and Its Competitors
Table 160. Hovione Inhalers Product Offered
Table 161. Hovione Inhalers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 162. Hovione Main Business
Table 163. Hovione Latest Developments

LIST OF FIGURES

Figure 1. Picture of Inhalers
Figure 2. Inhalers Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inhalers Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Inhalers Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Inhalers Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Metered Dose Inhalers
Figure 10. Product Picture of Dry Powder Inhalers
Figure 11. Product Picture of Nasal Inhalers
Figure 12. Product Picture of Other
Figure 13. Global Inhalers Sales Market Share by Type in 2021
Figure 14. Global Inhalers Revenue Market Share by Type (2017-2022)
Figure 15. Inhalers Consumed in Hospital
Figure 16. Global Inhalers Market: Hospital (2017-2022) & (K Units)
Figure 17. Inhalers Consumed in Clinic
Figure 18. Global Inhalers Market: Clinic (2017-2022) & (K Units)
Figure 19. Inhalers Consumed in Respiratory Care Centers
Figure 20. Global Inhalers Market: Respiratory Care Centers (2017-2022) & (K Units)
Figure 21. Inhalers Consumed in Others
Figure 22. Global Inhalers Market: Others (2017-2022) & (K Units)
Figure 23. Global Inhalers Sales Market Share by Application (2017-2022)
Figure 24. Global Inhalers Revenue Market Share by Application in 2021
Figure 25. Inhalers Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Inhalers Revenue Market Share by Company in 2021
Figure 27. Global Inhalers Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Inhalers Revenue Market Share by Geographic Region in 2021
Figure 29. Global Inhalers Sales Market Share by Region (2017-2022)
Figure 30. Global Inhalers Revenue Market Share by Country/Region in 2021
Figure 31. Americas Inhalers Sales 2017-2022 (K Units)
Figure 32. Americas Inhalers Revenue 2017-2022 ($ Millions)
Figure 33. APAC Inhalers Sales 2017-2022 (K Units)
Figure 34. APAC Inhalers Revenue 2017-2022 ($ Millions)
Figure 35. Europe Inhalers Sales 2017-2022 (K Units)
Figure 36. Europe Inhalers Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Inhalers Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Inhalers Revenue 2017-2022 ($ Millions)
Figure 39. Americas Inhalers Sales Market Share by Country in 2021
Figure 40. Americas Inhalers Revenue Market Share by Country in 2021
Figure 41. United States Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Inhalers Sales Market Share by Region in 2021
Figure 46. APAC Inhalers Revenue Market Share by Regions in 2021
Figure 47. China Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Inhalers Sales Market Share by Country in 2021
Figure 54. Europe Inhalers Revenue Market Share by Country in 2021
Figure 55. Germany Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Inhalers Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Inhalers Revenue Market Share by Country in 2021
Figure 62. Egypt Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Inhalers Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Inhalers in 2021
Figure 68. Manufacturing Process Analysis of Inhalers
Figure 69. Industry Chain Structure of Inhalers
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles


More Publications